These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 25023983)
1. HOXA9 promotes homotypic and heterotypic cell interactions that facilitate ovarian cancer dissemination via its induction of P-cadherin. Ko SY; Naora H Mol Cancer; 2014 Jul; 13():170. PubMed ID: 25023983 [TBL] [Abstract][Full Text] [Related]
2. P-cadherin promotes ovarian cancer dissemination through tumor cell aggregation and tumor-peritoneum interactions. Usui A; Ko SY; Barengo N; Naora H Mol Cancer Res; 2014 Apr; 12(4):504-13. PubMed ID: 24448686 [TBL] [Abstract][Full Text] [Related]
3. HOXA9 promotes ovarian cancer growth by stimulating cancer-associated fibroblasts. Ko SY; Barengo N; Ladanyi A; Lee JS; Marini F; Lengyel E; Naora H J Clin Invest; 2012 Oct; 122(10):3603-17. PubMed ID: 22945634 [TBL] [Abstract][Full Text] [Related]
4. Cadherin composition and multicellular aggregate invasion in organotypic models of epithelial ovarian cancer intraperitoneal metastasis. Klymenko Y; Kim O; Loughran E; Yang J; Lombard R; Alber M; Stack MS Oncogene; 2017 Oct; 36(42):5840-5851. PubMed ID: 28628116 [TBL] [Abstract][Full Text] [Related]
5. Expression of the homeobox gene HOXA9 in ovarian cancer induces peritoneal macrophages to acquire an M2 tumor-promoting phenotype. Ko SY; Ladanyi A; Lengyel E; Naora H Am J Pathol; 2014 Jan; 184(1):271-81. PubMed ID: 24332016 [TBL] [Abstract][Full Text] [Related]
7. AEG -1 overexpression: a novel indicator for peritoneal dissemination and lymph node metastasis in epithelial ovarian cancers. Li C; Liu J; Lu R; Yu G; Wang X; Zhao Y; Song H; Lin P; Sun X; Yu X; Zhang Y; Ning X; Geng J Int J Gynecol Cancer; 2011 May; 21(4):602-8. PubMed ID: 21543927 [TBL] [Abstract][Full Text] [Related]
8. Angiotensin II promotes ovarian cancer spheroid formation and metastasis by upregulation of lipid desaturation and suppression of endoplasmic reticulum stress. Zhang Q; Yu S; Lam MMT; Poon TCW; Sun L; Jiao Y; Wong AST; Lee LTO J Exp Clin Cancer Res; 2019 Mar; 38(1):116. PubMed ID: 30845964 [TBL] [Abstract][Full Text] [Related]
9. The histone demethylase KDM4B regulates peritoneal seeding of ovarian cancer. Wilson C; Qiu L; Hong Y; Karnik T; Tadros G; Mau B; Ma T; Mu Y; New J; Louie RJ; Gunewardena S; Godwin AK; Tawfik OW; Chien J; Roby KF; Krieg AJ Oncogene; 2017 May; 36(18):2565-2576. PubMed ID: 27869162 [TBL] [Abstract][Full Text] [Related]
10. Simultaneous E-cadherin and PLEKHA7 expression negatively affects E-cadherin/EGFR mediated ovarian cancer cell growth. Rea K; Roggiani F; De Cecco L; Raspagliesi F; Carcangiu ML; Nair-Menon J; Bagnoli M; Bortolomai I; Mezzanzanica D; Canevari S; Kourtidis A; Anastasiadis PZ; Tomassetti A J Exp Clin Cancer Res; 2018 Jul; 37(1):146. PubMed ID: 29996940 [TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA TC0101441 induces epithelial-mesenchymal transition in epithelial ovarian cancer metastasis by downregulating KiSS1. Qiu JJ; Lin XJ; Tang XY; Zheng TT; Zhang XY; Hua KQ Int J Cancer; 2020 May; 146(9):2588-2598. PubMed ID: 31577838 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of microRNA-196b Accelerates Invasiveness of Cancer Cells in Recurrent Epithelial Ovarian Cancer Through Regulation of Homeobox A9. Chong GO; Jeon HS; Han HS; Son JW; Lee YH; Hong DG; Park HJ; Lee YS; Cho YL Cancer Genomics Proteomics; 2017; 14(2):137-141. PubMed ID: 28387653 [TBL] [Abstract][Full Text] [Related]
13. Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic target. Sawada K; Mitra AK; Radjabi AR; Bhaskar V; Kistner EO; Tretiakova M; Jagadeeswaran S; Montag A; Becker A; Kenny HA; Peter ME; Ramakrishnan V; Yamada SD; Lengyel E Cancer Res; 2008 Apr; 68(7):2329-39. PubMed ID: 18381440 [TBL] [Abstract][Full Text] [Related]
14. SMYD3 promotes implant metastasis of ovarian cancer via H3K4 trimethylation of integrin promoters. Lyu T; Jiang Y; Jia N; Che X; Li Q; Yu Y; Hua K; Bast RC; Feng W Int J Cancer; 2020 Mar; 146(6):1553-1567. PubMed ID: 31503345 [TBL] [Abstract][Full Text] [Related]
15. The mannose receptor LY75 (DEC205/CD205) modulates cellular phenotype and metastatic potential of ovarian cancer cells. Faddaoui A; Bachvarova M; Plante M; Gregoire J; Renaud MC; Sebastianelli A; Gobeil S; Morin C; Macdonald E; Vanderhyden B; Bachvarov D Oncotarget; 2016 Mar; 7(12):14125-42. PubMed ID: 26871602 [TBL] [Abstract][Full Text] [Related]
16. Recombinant cell-permeable HOXA9 protein inhibits NSCLC cell migration and invasion. Yu SL; Koo H; Lee HY; Yeom YI; Lee DC; Kang J Cell Oncol (Dordr); 2019 Jun; 42(3):275-285. PubMed ID: 30697674 [TBL] [Abstract][Full Text] [Related]
17. Adaptation of ovarian cancer cells to the peritoneal environment: Multiple mechanisms of the developmental patterning gene Ko SY; Naora H Cancer Cell Microenviron; 2014 Nov; 1(6):e379. PubMed ID: 26000332 [TBL] [Abstract][Full Text] [Related]
18. A critical role of Oct4A in mediating metastasis and disease-free survival in a mouse model of ovarian cancer. Samardzija C; Luwor RB; Volchek M; Quinn MA; Findlay JK; Ahmed N Mol Cancer; 2015 Aug; 14():152. PubMed ID: 26260289 [TBL] [Abstract][Full Text] [Related]
19. microRNA-203 suppresses invasion of gastric cancer cells by targeting ERK1/2/Slug/ E-cadherin signaling. Gao P; Wang S; Jing F; Zhan J; Wang Y Cancer Biomark; 2017; 19(1):11-20. PubMed ID: 28269747 [TBL] [Abstract][Full Text] [Related]
20. Engagement of collagen-binding integrins promotes matrix metalloproteinase-9-dependent E-cadherin ectodomain shedding in ovarian carcinoma cells. Symowicz J; Adley BP; Gleason KJ; Johnson JJ; Ghosh S; Fishman DA; Hudson LG; Stack MS Cancer Res; 2007 Mar; 67(5):2030-9. PubMed ID: 17332331 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]